Advertisement

Clinical implications of young-onset pancreatic cancer patients after curative resection in Korea: a Korea Tumor Registry System Biliary Pancreas database analysis

Published:October 11, 2022DOI:https://doi.org/10.1016/j.hpb.2022.10.005

      Abstract

      Introduction

      This study evaluated the clinical characteristics and survival rate after curative resection of young age pancreatic cancer patients using Korea Tumor Registry System Biliary Pancreas (KOTUS-BP) Database analysis.

      Methods

      We compared demographics and clinical outcomes in patients under the age of 50 years (young age group) and those over the age of 65 years (standard group) between 1991 and 2017. We estimated the survival curve using the Kaplan–Meier method and the hazard ratio using the Cox proportional hazard model and 1:4 propensity matching analysis.

      Results

      A total of 2470 patients were analyzed, including 2091 in the standard group and 379 in the young age group. Survival analysis showed a better overall survival in the recently enrolled patients (2011–2017) in both the young age and standard groups (p = 0.001 and p = 0.005, respectively). Between 2011 and 2017, recurrence-free survival was shorter in the young age group (p = 0.02), but the overall survival was not significantly different between the two groups (p = 0.94).

      Conclusions

      Young-onset pancreatic cancer patients had more advanced stages at the time of diagnosis; however, the overall survival of both the young age and standard groups was similar due to adjuvant treatment after operation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to HPB
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rawla P.
        • Sunkara T.
        • Gaduputi V.
        Epidemiology of pancreatic cancer: global trends, etiology and risk factors.
        World J Oncol. 2019; 10: 10-27
        • Alese O.B.
        • Jiang R.
        • Shaib W.
        • Wu C.
        • Akce M.
        • Gaines T.
        • et al.
        Young adults with pancreatic cancer: national trends in treatment and outcomes.
        Pancreas. 2020; 49: 341-354
        • Ansari D.
        • Althini C.
        • Ohlsson H.
        • Andersson R.
        Early-onset pancreatic cancer: a population-based study using the SEER registry.
        Langenbeck’s Arch Surg. 2019; 404: 565-571
        • Li D.
        • Morris J.S.
        • Liu J.
        • Hassan M.M.
        • Day R.S.
        • Bondy M.L.
        • et al.
        Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
        JAMA. 2009; 301: 2553-2562
        • Luo G.
        • Zhang Y.
        • Guo P.
        • Ji H.
        • Xiao Y.
        • Li K.
        Global patterns and trends in pancreatic cancer incidence: age, period, and birth cohort analysis.
        Pancreas. 2019; 48: 199-208
        • Siegel R.L.
        • Miller K.D.
        • Fuchs H.E.
        • Jemal A.
        Cancer statistics, 2021.
        CA A Cancer J Clin. 2021; 71: 7-33
        • Bergmann F.
        • Aulmann S.
        • Wente M.N.
        • Penzel R.
        • Esposito I.
        • Kleeff J.
        • et al.
        Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40.
        J Clin Pathol. 2006; 59: 580-584
        • Frank S.A.
        Age-specific incidence of inherited versus sporadic cancers: a test of the multistage theory of carcinogenesis.
        Proc Natl Acad Sci USA. 2005; 102: 1071-1075
        • Eguchi H.
        • Yamaue H.
        • Unno M.
        • Mizuma M.
        • Hamada S.
        • Igarashi H.
        • et al.
        Clinicopathological characteristics of young patients with pancreatic cancer: an analysis of data from pancreatic cancer registry of Japan pancreas Society.
        Pancreas. 2016; 45: 1411-1417
        • He J.
        • Edil B.H.
        • Cameron J.L.
        • Schulick R.D.
        • Hruban R.H.
        • Herman J.M.
        • et al.
        Young patients undergoing resection of pancreatic cancer fare better than their older counterparts.
        J Gastrointest Surg. 2013; 17: 339-344
        • James T.A.
        • Sheldon D.G.
        • Rajput A.
        • Kuvshinoff B.W.
        • Javle M.M.
        • Nava H.R.
        • et al.
        Risk factors associated with earlier age of onset in familial pancreatic carcinoma.
        Cancer. 2004; 101: 2722-2726
        • Kang J.S.
        • Jang J.Y.
        • Kwon W.
        • Han Y.
        • Kim S.W.
        Clinicopathologic and survival differences in younger patients with pancreatic ductal adenocarcinoma-A propensity score-matched comparative analysis.
        Pancreatology. 2017; 17: 827-832
        • Luttges J.
        • Stigge C.
        • Pacena M.
        • Kloppel G.
        Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years - an analysis of its features and a literature review.
        Cancer. 2004; 100: 173-182
        • McWilliams R.R.
        • Maisonneuve P.
        • Bamlet W.R.
        • Petersen G.M.
        • Li D.H.
        • Risch H.A.
        • et al.
        Risk factors for early-onset and very-early-onset pancreatic adenocarcinoma A pancreatic cancer case-control consortium (PanC 4) analysis.
        Pancreas. 2016; 45: 311-316
        • Baek S.
        • Park S.H.
        • Won E.
        • Park Y.R.
        • Kim H.J.
        Propensity score matching: a conceptual review for radiology researchers.
        Korean J Radiol. 2015; 16: 286-296
        • Linden A.
        • Samuels S.J.
        Using balance statistics to determine the optimal number of controls in matching studies.
        J Eval Clin Pract. 2013; 19: 968-975
        • Szklo M.N.
        • Javier F.
        Epidemiology: beyond the basics.
        Jones & Bartlett Publishers, 2014: 324-329
        • Gehan E.A.
        A generalized Wilcoxon test for comparing arbitrarily Singly-censored Samples.
        Biometrika. 1965; 52: 203-223
        • Lee W.C.L.S.
        National health screening program of Korea.
        J Korean Med Assoc. 2010; 53: 363-370
        • Kim R.B.P.K.
        • Hong D.Y.
        • Lee C.H.
        • Kim J.R.
        Factors associated with cancer screening intention in eligible persons for national cancer screening program.
        J Prev Med Public Health. 2010; 43: 62-72
        • Cho B.L.C.
        Current situation of national health screening systems in Korea.
        J Korean Med Assoc. 2011; 54: 666-669
        • Lee W.C.K.Y.
        Background and significance of Korean national cancer screening guideline revision.
        J Korean Med Assoc. 2015; 58: 274-276
        • Tingstedt B.
        • Weitkamper C.
        • Andersson R.
        Early onset pancreatic cancer: a controlled trial.
        Ann Gastroenterol. 2011; 24: 206-212
        • Jemal A.
        • Siegel R.
        • Ward E.
        • Murray T.
        • Xu J.Q.
        • Smigal C.
        • et al.
        Cancer statistics.
        Ca - Cancer J Clin. 2006; 56 (2006): 106-130
        • Jung K.W.
        • Won Y.J.
        • Hong S.
        • Kong H.J.
        • Im J.S.
        • Seo H.G.
        Prediction of cancer incidence and mortality in Korea, 2021.
        Cancer Res Treat. 2021; 53: 316-322
        • Kweon S.S.
        Updates on cancer epidemiology in Korea.
        Chonnam Med J. 2018; 54 (2018): 90-100
        • Neoptolemos J.P.
        • Dunn J.A.
        • Stocken D.D.
        • Almond J.
        • Link K.
        • Beger H.
        • et al.
        Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
        Lancet. 2001; 358: 1576-1585
        • Oettle H.
        • Post S.
        • Neuhaus P.
        • Gellert K.
        • Langrehr J.
        • Ridwelski K.
        • et al.
        Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.
        JAMA. 2007; 297: 267-277
        • James V.
        • Archie B.
        Adolescent and young adult cancer biology.
        Cancer J. 2018; 24: 267-274
        • Yanai H.
        Nutrition for sarcopenia.
        J Clin Med Res. 2015; 7: 926-931